Palliative and adjuvant regional chemotherapy in pancreatic cancer

被引:46
|
作者
Link, KH
Gansauge, F
Gorich, J
Leder, GH
Rilinger, N
Beger, HG
机构
[1] UNIV ULM, DEPT GEN SURG, D-89075 ULM, GERMANY
[2] UNIV ULM, DEPT RADIOL 1, D-89075 ULM, GERMANY
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 1997年 / 23卷 / 05期
关键词
chemotherapy; pancreas; cancer; coeliac artery infusion; therapy;
D O I
10.1016/S0748-7983(97)93720-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To improve the dismal prognosis of patients (pts) with pancreatic cancer we treated 32 patients with non-resectable (UICC LII, 17 pts; UICC IC 15 pts-group 1) and 20 patients with resected (UICC I, 1 pt; UICC II, 3 pts; UICC III, 16 pts-group 2) pancreatic cancer with palliative (group I) and adjuvant post-operative (group II) coeliac axis intra-arterial cyclic infusions (CAI), CAI consisted of mitoxantrone 10 mg/m(2) on day 1, folinic acid 170 mg/m(2) and 5-FU 600 mg/m(2) during days 2-4, and cis-platinum 60 mg/m(2) on day 5 for up to 11 (group I) or six (group II) cycles, In a total of 211 cycles toxicities at the level of WHO III occurred in 0-6% and of WHO IV in 0%, The median survival times, compared with institutional historical controls (treated vs controls), were 12 vs 4.8 months in UICC III (P < 0.006) and 4 vs 2.9 months in UICC IV (P < 0.05) group I pts, and 21 vs 9.3 months in group II (P < 0.0003), Hepatic disease progression appeared to be suppressed with CAI, which also appears to be effective for palliative and adjuvant treatment in non-resectable and resected pancreatic cancer.
引用
收藏
页码:409 / 414
页数:6
相关论文
共 50 条
  • [21] Adjuvant and Palliative Chemotherapy for Colon Cancer in the Elderly Patient
    Power, Derek G.
    Lichtman, Stuart M.
    SEMINARS IN COLON AND RECTAL SURGERY, 2008, 19 (04) : 239 - 246
  • [22] Advances in palliative and adjuvant chemotherapy for the treatment of colon cancer
    Scheithauer, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (40) : 2118 - 2121
  • [23] PALLIATIVE AND ADJUVANT CHEMOTHERAPY OF METASTATIC RENAL-CANCER
    KUHBOCK, J
    POTZI, P
    MADARAS, T
    SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (02): : 116 - 123
  • [24] Present status of adjuvant chemotherapy for pancreatic cancer
    Takeda, Shin
    Nakao, Akimasa
    PANCREAS, 2008, 37 (01) : 112 - 112
  • [25] Adjuvant chemotherapy in elderly patients with pancreatic cancer
    A M Nagrial
    D K Chang
    N Q Nguyen
    A L Johns
    L A Chantrill
    J L Humphris
    V T Chin
    J S Samra
    A J Gill
    M Pajic
    M Pinese
    E K Colvin
    C J Scarlett
    A Chou
    J G Kench
    R L Sutherland
    L G Horvath
    A V Biankin
    British Journal of Cancer, 2014, 110 : 313 - 319
  • [26] Adjuvant chemotherapy in elderly patients with pancreatic cancer
    Nagrial, A. M.
    Chang, D. K.
    Nguyen, N. Q.
    Johns, A. L.
    Chantrill, L. A.
    Humphris, J. L.
    Chin, V. T.
    Samra, J. S.
    Gill, A. J.
    Pajic, M.
    Pinese, M.
    Colvin, E. K.
    Scarlett, C. J.
    Chou, A.
    Kench, J. G.
    Sutherland, R. L.
    Horvath, L. G.
    Biankin, A. V.
    BRITISH JOURNAL OF CANCER, 2014, 110 (02) : 313 - 319
  • [27] The Role of Neoadjuvant and Adjuvant Chemotherapy in Pancreatic Cancer
    Babu, Govind K.
    Koyyala, Venkata Pradeep Babu
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 315 - 321
  • [29] Effects of postoperative adjuvant chemotherapy and palliative chemotherapy on the gut microbiome in colorectal cancer
    Han Shuwen
    Yang Xi
    Pan Yuefen
    Xu Jiamin
    Qi Quan
    Liao Haihong
    Jiang Yizhen
    Wu Wei
    MICROBIAL PATHOGENESIS, 2020, 149
  • [30] Palliative chemotherapy in pancreatic cancer-treatment sequences
    Abbassi, Rami
    Alguel, Hana
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4